Stéphane Bancel, chief executive of Moderna, said the company is encouraged by the immune response and safety profile of the young cohort that was administered the vaccine.
“We look forward to filing with regulators globally and remain committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages,” he said.
Meanwhile, Anthony S. Fauci, the nation’s top infectious-disease expert, has expressed optimism that children 5 to 11 could start getting vaccinated against the coronavirus as soon as early November.
The FDA’s decision will then be examined by the Centers for Disease Control and Prevention, Fauci said Sunday on ABC News’s “This Week.”
“So, if all goes well . . . it’s entirely possible, if not very likely” that the Pfizer-BioNTech vaccine will be available to that age group “within the first week or two of November,” he said.